Morning Overview on MSN
The first cellular age-reversal therapy has been cleared for human trials
Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...
Soaring demand for rocket motors used to power missiles and other weapons has spurred new thinking about supply chains.
Donald Trump Jr., a GrabAGun investor, could benefit from a new administration proposal allowing home delivery of firearms.
Carla Tardi is a technical editor and digital content producer with 25+ years of experience at top-tier investment banks and money-management firms. Thomas J. Brock is a CFA and CPA with more than 20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results